Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Neoadjuvant chemotherapy (NAC) has been used in patients with advanced head and neck cancers (HNCs) with the intent of downstaging tumors and suppressing distant metastases. However, to the authors' knowledge, the perioperative impact of NAC has not been systematically explored in patients with HNC. The objective of the current study was to compare perioperative outcomes with surgery upfront compared with patients treated with NAC.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Between March 1, 2016, and March 31, 2019, patients undergoing surgery for HNC with flap reconstruction at The University of Texas MD Anderson Cancer Center in Houston were included. Data were extracted from the prospectively maintained National Surgical Quality Improvement Program database. Postoperative complications, return to operating room, and readmission rates were compared. Univariate and multivariate analyses of length of stay and overall and wound complications were performed.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>A total of 834 patients were analyzed, 687 of whom (82.4%) underwent surgery upfront and 147 of whom (17.6%) received NAC. A total of 631 cases (75.7%) involved the upper aerodigestive tract whereas 203 cases (24.3%) were cutaneous. A total of 317 patients (38.0%) had recurrent disease. The NAC group was younger (<i>P </i> < .001) and had less hypertension (<i>P </i> = .011), but had more advanced clinical stage tumors (<i>P </i> < .001) and surgeries with multiple flap reconstruction (<i>P </i> = .007). Patient groups did not differ with regard to wound complications (<i>P </i> = .47), return to operating room (<i>P </i> = .31), or readmission rates (<i>P </i> = .49). The NAC group received more blood transfusions (<i>P </i> < .001) but was found to have a lower risk of overall complications on multivariate analysis (odds ratio, 0.50; 95% CI, 0.30‐0.83). The overall complication rate was unchanged with surgery performed ≤21 days after the last chemotherapy cycle. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Patients undergoing NAC appear to have a higher disease burden but tend to be younger and healthier. Within the context of this inherent selection bias, NAC does not appear to increase perioperative morbidity among patients undergoing surgery for HNC.</p></section>

SUCCESSFUL PERIOPERATIVE MANAGEMENT OF HIGH-RISK ELDERLY PATIENTS WITH ADVANCED HEAD & NECK CANCER IN THE COVID ERA. OUR EXPERIENCE.

Head and neck cancer surgery during the COVID-19 pandemic: An international, multicenter, observational cohort study

The effect of COVID‐19 on surgical management of skin cancers of the head, face and neck in elderly patients

Laparoscopic cholecystectomy during the COVID-19 pandemic in a tertiary care hospital in Germany: higher rates of acute and gangrenous cholecystitis in elderly patients

Postoperative morbidity in head and neck cancer ablative surgery followed by microsurgical free tissue transfer in the elderly

Head and Neck Cancer Surgery in the Elderly

Recommendations for head and neck surgical procedures during the COVID-19 pandemic

Head and neck free flap reconstruction under the COVID-19 pandemic

Incidence and risk factors for morbidity and mortality in elderly head and neck cancer patients undergoing major oncological surgery

A combination of two regional flaps for the complex reconstruction after head and neck cancer surgery as an alternative approach during the COVID-19 pandemic: A case report

Head and Neck Cancer Patient Population, Management, and Oncologic Outcomes from the COVID-19 Pandemic

The Experience of the Maxillo-Facial Surgery Department of a French Regional Referral Center in a High-Incidence Area

Delayed presentation of head and neck cancer patients during COVID-19 pandemic

A Four-Year Retrospective Single-Center Study of 287 Patients

Study of Surgical Treatment for Elderly Patients with Head and Neck Cancer.

Head and Neck Cancer and the Elderly Patient

Impact of neoadjuvant chemotherapy on perioperative morbidity after major surgery for head and neck cancer

Perioperative Risk Assessment in the Surgical Care of Geriatric Patients

Safely Performing Neurosurgical Procedures During COVID-19 Pandemic.

CSF Rhinorrhea After Endonasal Intervention to the Skull Base (CRANIAL) - Part 2: Impact of COVID-19

Need for tracheostomy in major head and neck ablative surgery: a paradigm shift during the COVID-19 pandemic